France - English - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pimobendan 5 mg - chewable tablet - dogs - pimobendane

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - meloxicam - oxicams - horses; dogs; cattle; cats; pigs; guinea pigs - cats:alleviation of mild to moderate post-operative pain and inflammation following surgical procedures, e.g. orthopaedic and soft tissue surgery.alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders.reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.cattle:for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs.for use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for the relief of post-operative pain following dehorning in calves.for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.dogs:alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.horses:for use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.for the relief of pain associated with equine colic.alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.pigs: for use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.for the relief of post-operative pain associated with minor soft tissue surgery such as castration.for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.guinea pigs:alleviation of mild to moderate post-operative pain associated with soft tissues surgery such as male castration.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - meloxicam - anti-inflammatory and anti-rheumatic products, non-steroids - pigs; cattle - novem 5-mg/ml solution for injection for cattle and pigs:cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.for use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for the relief of postoperative pain following dehorning in calves.pigsfor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation.for the relief of postoperative pain associated with minor soft-tissue surgery such as castration.novem 20-mg/ml solution for injection for cattle and pigs:cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.for use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.for the relief of postoperative pain following dehorning in calves.pigsfor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation.for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.novem 40 mg/ml solution for injection for cattle:for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.for use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.

France - English - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pimobendan 1.25 mg - chewable tablet - dogs - pimobendane

France - English - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pimobendan 2.5 mg - chewable tablet - dogs - pimobendane

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - telmisartan - agents acting on the renin-angiotensin system, angiotensin ii antagonists, plain - cats - reduction of proteinuria associated with chronic kidney disease (ckd).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - maximum three of the following purified, inactivated foot-and-mouth disease virus strains: o1 manisa ≥ 6 pd50*; o1 bfs ≥ 6 pd50*; o taiwan 3/97 ≥ 6 pd50*; a22 iraq ≥ 6 pd50*; a24 cruzeiro ≥ 6 pd50*; a turkey 14/98 ≥ 6 pd50*; asia 1 shamir ≥ 6 pd50*; sat2 saudi arabia ≥ 6 pd50*; * pd50 – 50% protective dose in cattle as described in ph. eur. monograph 0063. - immunologicals - pigs; cattle; sheep - active immunisation of cattle, sheep and pigs from 2 weeks of age against foot-and-mouth disease to reduce clinical signs.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, fipronil, praziquantel, (s)-methoprene - antiparasitic products, insecticides and repellents, avermectins, eprinomectin, combinations, - cats - for cats with, or at risk from mixed infestations by cestodes, nematodes and ectoparasites. the veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.ectoparasitestreatment and prevention of infestations by fleas (ctenocephalides felis). elimination of fleas within 24 hours. one treatment prevents further infestations for at least one month.prevention of environmental flea contamination by inhibiting the development of flea immature stages (eggs, larvae and pupae) for over a month.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).treatment and prevention of infestations by ticks (ixodes ricinus). elimination of ticks within 48 hours. one treatment prevents further infestations for up to 3 weeks.treatment of notoedric mange (notoedres cati).cestodestreatment of infestations with tapeworms (dipylidium caninum, taenia taeniaeformis, echinococcus multilocularis, joyeuxiella pasqualei (adult), and joyeuxiella fuhrmanni (adult)).nematodestreatment of infestations with gastrointestinal nematodes (l3, l4 larvae and adults of toxocara cati, adults of toxascaris leonina, l4 larvae and adults of ancylostoma tubaeforme and ancylostoma ceylanicum, and adults of ancylostoma brazilienze).treatment of infestations with feline lungworms (l3 larvae, l4 larvae and adults of aelurostrongylus abstrusus, l4 larvae and adults of troglostrongylus brevior).treatment of infestations with vesical worms (capillaria plica).prevention of heartworm disease (dirofilaria immitis larvae) for one month.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - bluetongue-virus serotype-1 antigen, bluetongue virus serotype 8 antigen - immunologicals - sheep; cattle - sheepactive immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1,2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).cattleactive immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).active immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - canine herpesvirus (f205 strain) antigens - immunologicals for canidae - dogs - active immunisation of bitches to prevent mortality, clinical signs and lesions in puppies resulting from canine herpes virus infections acquired in the first few days of life.